Androgen levels of preeclamptic patients in the third trimester of pregnancy and six weeks after delivery

被引:63
作者
Serin, IS
Kula, M
Basbug, M
Ünlühizarci, KA
Güçer, S
Tayyar, M
机构
[1] Erciyes Univ, Fac Med, Dept Obstet & Gynecol, Kayseri, Turkey
[2] Erciyes Univ, Fac Med, Dept Nucl Med, Kayseri, Turkey
[3] Erciyes Univ, Fac Med, Dept Endocrinol, Kayseri, Turkey
关键词
androgens; pathogenesis; preeclampsia;
D O I
10.1034/j.1600-0412.2001.801107.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background. The aim of this study was to measure the circulating levels of androgens in the third trimester of pregnancy and six weeks after delivery and to discuss androgen contribution in the pathogenesis of preeclampsia. Methods. Twenty-two preeclamptic and 20 normotensive women completed this prospective study. Blood samples were drawn in the third trimester (28-32 gestational weeks) and six weeks after delivery. Serum total testosterone (T), free testosterone (fr) dehydroepiandrosterone sulfate (DHEAS), androstenodione (A), sex hormone binding globulin (SHBG) and estradiol (E-2) levels were measured. The statistical analyses of the data were performed by using Wilcoxon Rank test within the groups, Student unpaired t test and Chi-square test between the groups with the SPSS program. Results. T and fr levels were found to be significantly higher (p <0.05) in preeclamptic women in the third trimester compared to the values of normotensive controls. However, there were significant decreases (p <0.05) in T and fT levels six weeks after delivery, reaching values not significantly different from normotensive subjects (p >0.05). Futhermore, SHBG, DHEAS, A and E-2 levels were not significantly different (p >0.05) between the groups in the third trimester or six weeks after delivery. Conclusion. We conclude that higher blood androgen levels measured in preeclamptic patients may be implicated in the pathogenesis of preeclampsia.
引用
收藏
页码:1009 / 1013
页数:5
相关论文
共 22 条
[11]   Preeclampsia and breast cancer risk [J].
Innes, KE ;
Byers, TE .
EPIDEMIOLOGY, 1999, 10 (06) :722-732
[12]   Evidence of high circulating testosterone in women with prior preeclampsia [J].
Laivuori, H ;
Kaaja, R ;
Rutanen, EM ;
Viinikka, L ;
Ylikorkala, O .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :344-347
[13]   THE CELL-ADHESION MOLECULE, VCAM-1, IS SELECTIVELY ELEVATED IN SERUM IN PREECLAMPSIA - DOES THIS INDICATE THE MECHANISM OF LEUKOCYTE ACTIVATION [J].
LYALL, F ;
GREER, IA ;
BOSWELL, F ;
MACARA, LM ;
WALKER, JJ ;
KINGDOM, JCP .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1994, 101 (06) :485-487
[14]   RELATIVE ANDROGENICITY, BLOOD-PRESSURE LEVELS, AND CARDIOVASCULAR RISK-FACTORS IN YOUNG HEALTHY WOMEN [J].
MANTZOROS, CS ;
GEORGIADIS, EI ;
YOUNG, R ;
EVAGELOPOULOU, C ;
KHOURY, S ;
KATSILAMBROS, N ;
SOWERS, JR .
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (06) :606-614
[15]   Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1 [J].
McCrohon, JA ;
Jessup, W ;
Handelsman, DJ ;
Celermajer, DS .
CIRCULATION, 1999, 99 (17) :2317-2322
[16]   METABOLISM OF ANDROSTENEDIONE BY HUMAN-PLATELETS - A SOURCE OF POTENT ANDROGENS [J].
MILEWICH, L ;
WHISENANT, MG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 54 (05) :969-974
[17]   PREECLAMPSIA RELATED TO A FUNCTIONING EXTRAUTERINE PLACENTA - REPORT OF A CASE AND 25-YEAR FOLLOW-UP [J].
PIERING, WF ;
GARANCIS, JG ;
BECKER, CG ;
BERES, JA ;
LEMANN, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (03) :310-313
[18]   Serum alpha-inhibin levels in polycystic ovary syndrome: Relationship to the serum androstenedione level [J].
Pigny, P ;
Desailloud, R ;
CortetRudelli, C ;
Duhamel, A ;
DeroubaixAllard, D ;
Racadot, A ;
Dewailly, D .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1939-1943
[19]   Impaired glucose tolerance in pregnant women with polycystic ovary syndrome [J].
Radon, PA ;
McMahon, MJ ;
Meyer, WR .
OBSTETRICS AND GYNECOLOGY, 1999, 94 (02) :194-197
[20]   Role of androgens in mediating hypertension and renal injury [J].
Reckelhoff, JF ;
Granger, JP .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (02) :127-131